FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LISAFTOCLAX
异名/同义词4-(4-((6-(4-CHLOROPHENYL)SPIRO(3.5)NON-6-EN-7-YL)METHYL)-PIPERAZIN-1-YL)-N-((3-NITRO-4-(((2S)-1,4-DIOXAN-2-YLMETHYL)AMINO)PHENYL)SULFONYL)-2-(1HPYRROLO(2,3-B)PYRIDIN-5-YLOXY)BENZAMIDE
APG2575
APG-2575
BENZAMIDE, 4-(4-((6-(4-CHLOROPHENYL)SPIRO(3.5)NON-6-EN-7-YL)METHYL)-1-PIPERAZINYL)-N-((4-(((2S)-1,4-DIOXAN-2-YLMETHYL)AMINO)-3-NITROPHENYL)SULFONYL)-2-(1H-PYRROLO(2,3-B)PYRIDIN-5-YLOXY)-
LISAFTOCLAX
LISAFTOCLAX [INN]
LISAFTOCLAX [WHO-DD]
CAS登记号2180923-05-9
物质唯一标识(Unique Ingredient Identifier)OSL3FEZ1IF
分子式C45H48ClN7O8S
国际化合物标识(International Chemical Identifier,InChI)FNBXDBIYRAPDPI-BHVANESWSA-N
SMILESC(c1c(cc(cc1)N2CCN(CC2)CC3=C(CC4(CCC4)CC3)c5ccc(cc5)Cl)Oc6cc7c(nc6)[nH]cc7)(=O)NS(=O)(=O)c8cc(c(cc8)NC[C@@H]9OCCOC9)[N+](=O)[O-]
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System